Compression and CO2 Laser for Leg Wounds
NCT: NCT04198454 · ENROLLING_BY_INVITATION
Brief Summary
The purpose of this study is to determine the efficacy and safety of compression bandaging with fractional ablative carbon dioxide laser (FACL) compared to compression and standard dressings alone for healing of post-operative wounds of the leg. This is a randomized, SMART design, clinical trial. Approximately 80 participants will be randomized to initially receive compression bandages or standard wound dressings after surgery on the lower leg. After 4 weeks, the group assigned to compression bandages will be further randomized to either continue with the compression bandages only or continue with the compression bandages and also receive (FACL). The study is designed as an 6-month study. This study was a pilot study designed to determine feasibility of these procedure. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.
Frequently Asked Questions
What is Compression and CO2 Laser for Leg Wounds?
Compression and CO2 Laser for Leg Wounds is a clinical trial registered under NCT04198454. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT04198454?
The current status of NCT04198454 (Compression and CO2 Laser for Leg Wounds) is: ENROLLING_BY_INVITATION.
When did Compression and CO2 Laser for Leg Wounds start?
Compression and CO2 Laser for Leg Wounds started on 2020-02-17.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.